Care of the Brain-Dead Organ Donor

Abstract

There remains a worldwide shortage of organs for transplantation. If not properly cared for, the organs of patients who are brainstem dead will deteriorate, making them either unsuitable for transplantation or reducing the success rate of transplants. The Medline database was searched with no time limit in January 2019 for English publications using keywords “brainstem death physiology” and “organ donor care.” Full texts of all publications related to care of deceased donors after brainstem death (DBD) were reviewed. Those that were not relevant were excluded. An online search for publications and guidelines produced by international organizations relating to organ donation and care of the organ donor was also preformed, and the results were reviewed.

Although there is a low level of evidence to support specific management strategies to optimize the care of potential DBD patients, there is reasonable consensus between different international guidelines on protocolized intensive care unit (ICU) management of potential DBD patients and donor resuscitation targets.

Key management concepts include (1) early recognition of brainstem DBD and referral to organ donation services, (2) ICU-led multidisciplinary team (MDT) approach to donor management, (3) shift in ICU teams thinking from management of raised intracranial pressure (ICP) to maintaining organ perfusion and function, (4) early active donor management to normalize donor physiology, and (5) prevention, recognition, and treatment of complications of brainstem death.

Keywords

brainstem death physiology - organ donor care - organ transplant

• References

• 1 NHS Blood and Transplant. Organ Donation and Transplantation Activity Report. 2017/18[Online]. Available at: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/12300/transplant-activity-report-2017-2018.pdf Accessed January 1, 2018
• 2 Academy of Medical Royal Colleges. “A Code of Practice for the Diagnosis and Confirmation of Death.”. AoMRC. 2008 [Online]. Available at: http://www.aomrc.org.uk Accessed January 1, 2018
• 3 Report from the Organ Donation Taskforce. “Organs for transplant”;. 2008 [Online]. Available at: https://webarchive.nationalarchives.gov.uk/20130105051141 http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicy-AndGuidance/DH_082122 Accessed January 1, 2018
• 4 National Institute for Clinical Excellence (NICE). Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation. Issue date: December 2011. NICE guideline CG135. Last updated December 2016. [Online]. Available at: https://www.nice.org.uk/guidance/cg135/evidence/full-guideline-184994893 Accessed January 1, 2018
• 5 Reyes KG, Mason DP, Thuita L. et al. Guidelines for donor lung selection: time for revision?. Ann Thorac Surg 2010; 89 (06) 1756-1764 discussion 1764–1765
• 6 Bugge JF. Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand 2009; 53 (10) 1239-1250
• 7 Smith M. Physiologic changes during brain stem death—lessons for management of the organ donor. J Heart Lung Transplant 2004; 23 (09) Suppl S217-S222
• 8 Robert R, Guilhot J, Pinsard M. et al. A pair analysis of the delayed graft function in kidney recipient: the critical role of the donor. J Crit Care 2010; 25 (04) 582-590
• 9 Venkateswaran RV, Patchell VB, Wilson IC. et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008; 85 (01) 278-286 discussion 286
• 10 Rosendale JD, Chabalewski FL, McBride MA. et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002; 2 (08) 761-768
• 11 Rech TH, Moraes RB, Crispim D, Czepielewski MA, Leitão CB. Management of the brain-dead organ donor: a systematic review and meta-analysis. Transplantation 2013; 95 (07) 966-974
• 12 Prout J, Jones T, Martin D. eds. Advanced training in Anaesthesia the Essential Curriculum. Oxford, UK: Oxford University Press; 2014: 402-403
• 13 Dictus C, Vienenkoetter B, Esmaeilzadeh M, Unterberg A, Ahmadi R. Critical care management of potential organ donors: our current standard. Clin Transplant 2009; 23 (Suppl. 21) 2-9
• 14 Agrawal A, Timothy J, Cincu R, Agarwal T, Waghmare LB. Bradycardia in neurosurgery. Clin Neurol Neurosurg 2008; 110 (04) 321-327
• 15 Fraser JF, Nataatmadja M, Passmore M. et al. Brain stem death induced pulmonary hypertension—more pronounced and prolonged than left ventricular changes in an ovine model. J Heart Lung Transplant 2009; 18 (01) 74
• 16 Halejcio-Delophont P, Siaghy EM, Devaux Y. et al. Increase in myocardial interstitial adenosine and net lactate production in brain-dead pigs: an in vivo microdialysis study. Transplantation 1998; 66 (10) 1278-1284
• 17 Shivalkar B, Van Loon J, Wieland W. et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993; 87 (01) 230-239
• 18 Novitzky D, Rhodin J, Cooper DK, Ye Y, Min KW, DeBault L. Ultrastructure changes associated with brain death in the human donor heart. Transpl Int 1997; 10 (01) 24-32
• 19 ODT clinical, . Donor optimisation: Guidance around selecting potential DBD donors [Online].. Available at: https://www.odt.nhs.uk/deceased-donation/best-practice-guidance/donor-optimisation/ Accessed January 1, 2018
• 20 Chudoba P, Krajewski W, Wojciechowska J, Kamińska D. Brain death-associated pathological events and therapeutic options. Adv Clin Exp Med 2017; 26 (09) 1457-1464
• 21 Avlonitis VS, Wigfield CH, Kirby JA, Dark JH. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 2005; 5 (04) Pt 1 684-693
• 22 McKeown DW, Bonser RS, Kellum JA. Management of the heart beating brain-dead organ donor. Br J Anaesth 2012; 108 (Suppl. 01) i96-i107
• 23 Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation 2006; 82 (11) 1396-1401
• 24 Gramm HJ, Meinhold H, Bickel U. et al. Acute endocrine failure after brain death?. Transplantation 1992; 54 (05) 851-857
• 25 Chen EP, Bittner HB, Kendall SW, Van Trigt P. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med 1996; 24 (08) 1352-1359
• 26 Dimopoulou I, Tsagarakis S, Anthi A. et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Crit Care Med 2003; 31 (04) 1113-1117
• 27 Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL. Hormonal changes in brain dead patients. Crit Care Med 1990; 18 (07) 702-708
• 28 Masson F, Thicoïpe M, Latapie MJ, Maurette P. Thyroid function in brain-dead donors. Transpl Int 1990; 3 (04) 226-233
• 29 Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43 (06) 852-854
• 30 Domi R, Sula H, Ohri I, Laho H. Pathophysiologic changes after brain death and organ preservation: the intensivist's and anesthesiologist's role. J Anesth Clin Res 2013; 4 (03) 1-4
• 31 Salim A, Vassiliu P, Velmahos GC. et al. The role of thyroid hormone administration in potential organ donors. Arch Surg 2001; 136 (12) 1377-1380
• 32 Masson F, Thicoipe M, Gin H. et al. The endocrine pancreas in brain-dead donors. A prospective study in 25 patients. Transplantation 1993; 56 (02) 363-367
• 33 Hefty TR, Cotterell LW, Fraser SC, Goodnight SH, Hatch TR. Disseminated intravascular coagulation in cadaveric organ donors. Incidence and effect on renal transplantation. Transplantation 1993; 55 (02) 442-443
• 34 Pratschke J, Wilhelm MJ, Kusaka M. et al. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000; 232 (02) 263-271
• 35 Shemie SD, Ross H, Pagliarello J. et al; Pediatric Recommendations Group. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. CMAJ 2006; 174 (06) S13-S32
• 36 Zaroff JG, Rosengard BR, Armstrong WF. et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations March 28–29 2001, Crystal City, Va. Circulation 2002; 106 (07) 836-41
• 37 Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB. Care of the potential organ donor. N Engl J Med 2004; 351 (26) 2730-2739
• 38 United Network for Organ Sharing (UNOS). Critical Pathway for Organ Donor. UNOS. 2002 [Online]. Available at: https://www.unos.org/wp-content/uploads/unos/Critical_Pathway.pdf Accessed January 1, 2018
• 39 Faculty of Intensive Care Medicine (FICM). Form for the Diagnosis of Death using Neurological Criteria [full guidance version]. FICM. 2014 [Online]. Available at: https://www.ficm.ac.uk/sites/default/files/Form%20for%20the%20Diagnosis%20of%20Death%20using%20Neurological%20Criteria%20-%20Full%20Version%20%282014%29.pdf Accessed January 1, 2018
• 40 Mandersloot G. Donation after Brainstem Death (DBD) Donor Optimisation Extended Care Bundle version 2009–2012. National Organ Donation Committee. 2012 [Online]. Available at: https://www.odt.nhs.uk/deceased-donation/best-practice-guidance/donor-optimisation/ Accessed January 1, 2018
• 41 Chapter 9: The donor. In: Eurotransplant Manual—version 4.3; June 2, 2015. [Online]. Available at: https://eurotransplant.org/cms/mediaobject.php?file=H9+The+Donor_August+20161.pdf Accessed January 1, 2018
• 42 Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the “unacceptable” donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14 (04) 734-742
• 43 Al-Khafaji A, Elder M, Lebovitz DJ. et al. Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med 2015; 41 (03) 418-426
• 44 Venkateswaran RV, Townend JN, Wilson IC, Mascaro JG, Bonser RS, Steeds RP. Echocardiography in the potential heart donor. Transplantation 2010; 89 (07) 894-901
• 45 Vijay P, Scavo VA, Morelock RJ, Sharp TG, Brown JW. Donor cardiac troponin T: a marker to predict heart transplant rejection. Ann Thorac Surg 1998; 66 (06) 1934-1939
• 46 Audibert G, Charpentier C, Seguin-Devaux C. et al. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation 2006; 82 (08) 1031-1036
• 47 Gordon JK, McKinlay J. Physiological changes after brain stem death and management of the heart-beating donor. Contin Educ Anaesth Crit Care Pain 2012; 12 (05) 225-229
• 48 Murugan R, Venkataraman R, Wahed AS. et al; HIDonOR Study Investigators. Preload responsiveness is associated with increased interleukin-6 and lower organ yield from brain-dead donors. Crit Care Med 2009; 37 (08) 2387-2393
• 49 Randell T, Orko R, Höckerstedt K. Peroperative fluid management of the brain-dead multiorgan donor. Acta Anaesthesiol Scand 1990; 34 (07) 592-595
• 50 Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348 (9042) 1620-1622
• 51 Limnell N, Schramko AA. Is brain-dead donor fluid therapy with colloids associated with better kidney grafts?. Exp Clin Transplant 2018; 16 (01) 55-60
• 52 Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation 1993; 56 (06) 1418-1422
• 53 Angel LF, Levine DJ, Restrepo MI. et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 2006; 174 (06) 710-716
• 54 Miñambres E, Rodrigo E, Ballesteros MA. et al. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation. Nephrol Dial Transplant 2010; 25 (07) 2352-2356
• 55 Iwai A, Sakano T, Uenishi M, Sugimoto H, Yoshioka T, Sugimoto T. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation 1989; 48 (04) 613-617
• 56 Chen JM, Cullinane S, Spanier TB. et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999; 100 (19) Suppl II244-II246
• 57 Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120 (03) 989-1002
• 58 Stoica SC, Satchithananda DK, White PA, Parameshwar J, Redington AN, Large SR. Noradrenaline use in the human donor and relationship with load-independent right ventricular contractility. Transplantation 2004; 78 (08) 1193-1197
• 59 D'Amico TA, Meyers CH, Koutlas TC. et al. Desensitization of myocardial beta-adrenergic receptors and deterioration of left ventricular function after brain death. J Thorac Cardiovasc Surg 1995; 110 (03) 746-751
• 60 Schnuelle P, Yard BA, Braun C. et al. Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant 2004; 4 (03) 419-426
• 61 Schnuelle P, Gottmann U, Hoeger S. et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009; 302 (10) 1067-1075
• 62 Lauschke A, Teichgräber UK, Frei U, Eckardt KU. ‘Low-dose’ dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006; 69 (09) 1669-1674
• 63 Debaveye YA, Van den Berghe GH. Is there still a place for dopamine in the modern intensive care unit?. Anesth Analg 2004; 98 (02) 461-468
• 64 De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 2012; 40 (03) 725-730
• 65 Mascia L, Pasero D, Slutsky AS. et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 2010; 304 (23) 2620-2627
• 66 Schnuelle P, Berger S, de Boer J, Persijn G, van der Woude FJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001; 72 (03) 455-463
• 67 Totsuka E, Dodson F, Urakami A. et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg 1999; 5 (05) 421-428
• 68 Mangus RS, Fridell JA, Vianna RM. et al. Severe hypernatremia in deceased liver donors does not impact early transplant outcome. Transplantation 2010; 90 (04) 438-443
• 69 Mackersie RC, Bronsther OL, Shackford SR. Organ procurement in patients with fatal head injuries. The fate of the potential donor. Ann Surg 1991; 213 (02) 143-150
• 70 Rosendale JD, Kauffman HM, McBride MA. et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003; 75 (04) 482-487
• 71 Rosendale JD, Kauffman HM, McBride MA, Skjei TC. Hormonal resuscitation associated with more transplanted organs with no sacrifice in survival. Transplantation 2004; 78 (02) 17
• 72 Macdonald PS, Aneman A, Bhonagiri D. et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med 2012; 40 (05) 1635-1644
• 73 Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid 1997; 7 (01) 139-145
• 74 Novitzky D, Mi Z, Sun Q, Collins JF, Cooper DK. Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: a retrospective analysis. Transplantation 2014; 98 (10) 1119-1127
• 75 Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998; 17 (04) 423-429
• 76 Kotsch K, Ulrich F, Reutzel-Selke A. et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008; 248 (06) 1042-1050
• 77 Chatterjee SN, Terasaki PI, Fine S, Schulman B, Smith R, Fine RN. Pretreatment of cadaver donors with methylprednisolone in human renal allografts. Surg Gynecol Obstet 1977; 145 (05) 729-732
• 78 Pinsard M, Ragot S, Mertes PM. et al. Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study. Crit Care 2014; 18 (04) R158
• 79 Sharman A, Low J. Vasopressin and its role in critical care. Contin Educ Anaesth Crit Care Pain 2008; 8 (04) 134-137
• 80 Blasi-Ibanez A, Hirose R, Feiner J. et al. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology 2009; 110 (02) 333-341
• 81 Niemann CU, Feiner J, Swain S. et al. Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med 2015; 373 (05) 405-414
• 82 National Institute for Clinical Excellence (NICE). Blood transfusion. NICE guideline. November 2015 [Online]. Available at: nice.org.uk/guidance/ng24 Accessed January 1, 2018
• 83 Singbartl K, Murugan R, Kaynar AM. et al. Intensivist-led management of brain-dead donors is associated with an increase in organ recovery for transplantation. Am J Transplant 2011; 11 (07) 1517-1521
• 84 Cantin B, Kwok BW, Chan MC. et al. The impact of brain death on survival after heart transplantation: time is of the essence. Transplantation 2003; 76 (09) 1275-1279
• 85 Inaba K, Branco BC, Lam L. et al. Organ donation and time to procurement: late is not too late. J Trauma 2010; 68 (06) 1362-1366
• 86 Nijboer WN, Moers C, Leuvenink HGD, Ploeg RJ. How important is the duration of the brain death period for the outcome in kidney transplantation?. Transpl Int 2011; 24 (01) 14-20
• 87 Wauters S, Verleden GM, Belmans A. et al. Donor cause of brain death and related time intervals: does it affect outcome after lung transplantation?. Eur J Cardiothorac Surg 2011; 39 (04) e68-e76
• 88 Salim A, Velmahos GC, Brown C, Belzberg H, Demetriades D. Aggressive organ donor management significantly increases the number of organs available for transplantation. J Trauma 2005; 58 (05) 991-994
• 89 Straznicka M, Follette DM, Eisner MD, Roberts PF, Menza RL, Babcock WD. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002; 124 (02) 250-258